Feasibility of Telemedicine Medical Abortion

This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnancy

Age range

10 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

Planned Parenthood of the Rocky Mountains, Denver, Colorado, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

desires abortion

Exclusion criteria

medically ineligible for procedure

Treatment and study plan

Medical Abortion

Drug

medical abortion

Primary outcomes

Number of participants with adverse events

Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Gynuity Health Projects

Other

Registry information

Official study title

TelAbortion: Medical Abortion by Direct-to-patient Telemedicine and Mail

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Oct 23, 2020
Registry last updated: Feb 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed